Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
21.68
+0.30 (1.40%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $1.4 billion as of August 21, 2026. Its market cap has increased by 216.17% in one year.
Market Cap
1.40B
Enterprise Value
1.06B
1-Year Change
216.17%
Ranking
Category
Stock Price
$21.68
ChartMarket Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $1.40B, an increase of 68.21%. That is a compound annual growth rate of 9.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.40B | 128.18% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.44B |
| Savara | 1.42B |
| Latigo Biotherapeutics | 1.41B |
| Omeros | 1.39B |
| Replimune Group | 1.39B |
| Vor Biopharma | 1.38B |
| Alpha Tau Medical | 1.38B |
| MeiraGTx Holdings | 1.38B |